申请人:John Wyeth and Brother Limited
公开号:US04415579A1
公开(公告)日:1983-11-15
The invention relates to a pharmaceutical composition comprising an anti-ulcer effective amount of a compound of formula I ##STR1## wherein R represents hydrogen, lower alkyl, phenyl, halophenyl, loweralkylphenyl, loweralkoxyphenyl, or aralkyl of 7 to 12 carbon atoms, R.sup.1 represents hydrogen or lower alkoxy, R.sup.2 represents hydrogen, chlorine or trifluoromethyl and n is 1 or 2, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable carrier. A method of treating ulcers or hypersecretion in a mammal which comprises administering a compound of formula I is also disclosed. Some compounds of formula I are novel and within the scope of the invention.
本发明涉及一种药物组合物,包括化合物I的抗溃疡有效量,其中I的结构式为:##STR1##其中R表示氢,低碳基,苯基,卤代苯基,低碳基苯基,低碳氧基苯基或7至12个碳原子的芳基烷基,R.sup.1表示氢或低碳氧基,R.sup.2表示氢,氯或三氟甲基,n为1或2,或其药学上可接受的酸盐,并且药学上可接受的载体。本发明还公开了一种治疗哺乳动物溃疡或高分泌的方法,该方法包括给予化合物I。其中,化合物I的某些化合物是新颖的,并在本发明的范围内。